WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) was up 16.3% during mid-day trading on Thursday. The stock traded as high as $25.9070 and last traded at $25.9070. 929 shares were traded during mid-day trading, a decline of 82% from the average session volume of 5,283 shares. The stock had previously closed at $22.28.
Analysts Set New Price Targets
Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.
Get Our Latest Report on WuXi AppTec
WuXi AppTec Stock Down 0.8%
The firm’s 50-day simple moving average is $25.38 and its 200 day simple moving average is $19.46.
WuXi AppTec Company Profile
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
Read More
- Five stocks we like better than WuXi AppTec
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
